An amyloid beta vaccine that safely drives immunity to a key pathological species in Alzheimer's disease: pyroglutamate amyloid beta.

Published in:

Brain Communications, 2022, v. 4, n. 1, p. 1, doi. 10.1093/braincomms/fcac022

By:

• Vukicevic, M.;
• Fiorini, E.;
• Siegert, S.;
• Carpintero, R.;
• Rincon-Restrepo, M.;
• Lopez-Deber, P.;
• Piot, N.;
• Ayer, M.;
• Rentero, I.;
• Babolin, C.;
• Bravo-Veyrat, S.;
• Giriens, V.;
• Morici, C.;
• Beuzelin, M.;
• Gesbert, A.;
• Rivot, S.;
• Depretti, S.;
• Donati, P.;
• Streffer, J.;
• Pfeifer, A.

Publication type:

Article